Wallis Lau

Lecturer in Pharmacoepidemiology and Drug Safety

UCL School of Pharmacy

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Wallis Lau is a Lecturer in Pharmacoepidemiology and Drug Safety at the UCL School of Pharmacy in the UK. His research focuses on the safety and effectiveness of medications, notably examining the risks of self-harm associated with leukotriene receptor antagonists and inhaled corticosteroids, as well as the clinical impact of antibiotic allergies. He has contributed to various studies addressing topics such as the relationship between lithium use and fracture risk in bipolar disorder patients, and trends in benzodiazepine consumption over the last decade.

Articles (18)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

Isla Mackenzie

Academic, Clinical Professor (Teaching and Research) of Cardiovascular Medicine

University of Dundee

UNITED KINGDOM

View details

Yogini Jani

University College London Hospitals NHS Foundation Trust

UNITED KINGDOM

View details

Ian Chi Kei Wong

Aston University

UNITED KINGDOM

View details

Li Wei

University College London

UNITED KINGDOM

View details

Zixuan Wang

Assistant Professor

University of Birmingham

UNITED KINGDOM

View details

Kenneth Man

University College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Wallis Lau

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Risk of self-harm and the use of leukotriene receptor antagonists and inhaled corticosteroids: a population-based study

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: A population-based cohort study

Unveiling unique clinical phenotypes of hip fracture patients and the temporal association with cardiovascular events

Lithium and the risk of fractures in patients with bipolar disorder: A population-based cohort study

Effect of statin treatment on the risk of cancer in patients with heart failure

Sex-specific comparative outcomes between oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis

Gabapentinoid consumption in 65 countries and regions from 2008 to 2018: a longitudinal trend study

Treatment with methylphenidate and the risk of fractures among children and young people: A systematic review and self‐controlled case series study

Association between the mood stabilizing treatment of bipolar disorder and risk of suicide attempts: A self-controlled case series study

Global trends in the consumption of benzodiazepines and Z-drugs in 67 countries and regions from 2008 to 2018: a sales data analysis

Attention deficit hyperactivity disorder, physical abuse and methylphenidate treatment in children

Antibiotic prescribing in general practice during COVID-19 and beyond

Attention-deficit/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: a longitudinal study

Comparative Effectiveness and Safety between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban among Patients with Atrial Fibrillation

Development and validation of sex-specific hip fracture prediction models using electronic health records: a retrospective, population-based cohort study

Maternal Benzodiazepines and Z-Drugs Use during Pregnancy and Adverse Birth and Neurodevelopmental Outcomes in Offspring: A Population-Based Cohort Study

Effectiveness of Facebook Groups and Pages on Participant Recruitment Into a Randomized Controlled Trial During the COVID-19 Pandemic: Descriptive Study

Global trends in the consumption of benzodiazepines and Z-drugs in 67 countries and regions from 2008 to 2018: a sales data analysis

Collaborators (6)

Isla Mackenzie

Yogini Jani

Ian Chi Kei Wong

Li Wei

Zixuan Wang

Kenneth Man

Make your next move.